jadelle - leitarniðurstöður

Namibía - enska - Namibia Medicines Regulatory Council

jadelle

bayer (pty) ltd - levonorgestrel - implant - each implant contains; levonorgestrel 75 mg

Filippseyjar - enska - FDA (Food And Drug Administration)

jadelle 75mg implant (for subdermal use only)

bayer philippines, inc.; importer: n/a; distributor: n/a - levonorgestrel - implant (for subdermal use only) - 75mg

Nígería - enska - NAFDAC (National Agency for Food and Drugs Administration and Control)

jadellesine inseter (pom)

levonorgestrel 75mg

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

erivedge

roche products pty ltd - vismodegib -

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

erivedge

roche products (nz) ltd - vismodegib 150mg; - capsule - 150 mg - active: vismodegib 150mg excipient: gelatin iron oxide black iron oxide red lactose monohydrate magnesium stearate microcrystalline cellulose opacode black s-1-17822 opacode black s-1-17823 povidone purified talc sodium laurilsulfate sodium starch glycolate titanium dioxide - indicated for the treatment of adult patients with metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma where surgery and/or radiation therapy are not appropriate.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

erivedge vismodegib 150 mg hard capsule bottle

roche products pty ltd - vismodegib, quantity: 150 mg - capsule, hard - excipient ingredients: purified talc; iron oxide red; gelatin; sodium starch glycollate; microcrystalline cellulose; titanium dioxide; iron oxide black; shellac; lactose monohydrate; povidone; magnesium stearate; sodium lauryl sulfate - erivedge is indicated for the treatment of adult patients with metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma where surgery and/or radiation therapy are not appropriate.